Blood pressure and estimated risk of stroke in the elderly population of Spain: The PREV-ICTUS study

Stroke

Volumn 38, Issue 4, 2007, Pages 1167-1173

  Redón, Josep ^a,g   Cea Calvo, Luis ^b   Lozano, José V ^c   Martí Canales, Juan C ^d   Llisterri, José L ^e   Aznar, Jose ^f   González Esteban, Jorge ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Medical affairs Merck sharp and Dohme ltd   (Spain)

^c Serreria 2 Health Center   (Spain)

^d Orcera Health Center   (Spain)

^e Ingeniero Joaquin Benlloch Health Center   (Spain)

^f HOSPITAL MARINA ALTA   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Blood pressure; Elderly; Hypertension; Risk factors; Stroke

Indexed keywords

AGED; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CLINICAL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPAIN; STROKE; AGE DISTRIBUTION; AGING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMORBIDITY; CROSS-SECTIONAL STUDY; HEART LEFT VENTRICLE HYPERTROPHY; MIDDLE AGED; MULTICENTER STUDY;

AGE DISTRIBUTION; AGED; AGING; ATRIAL FIBRILLATION; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SPAIN;

EID: 34247862362     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000259815.51547.31     Document Type: Article

References (34)

1. Ministerio de Sanidad y Consumo. Estadísticas y publicaciones. Disponible en: http://www.msc.es/estadEstudios/estadisticas/inforRecopilaciones/ mortalidad/tablasSeleccion.htm. Accessed on: July 1, 2006.
2. Regidor E, Gutiérrez-Fisac JL, Calle ME, Otero A. Mortality patterns in Spain, 1998. Med Clin (Barc). 2002;118:13-15.
3. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet. 2003;362:1211-1224.
4. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
5. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-2369.
6. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998;32:998-1002.
7. Banegas JR, Rodriguez-Artalejo F, Ruilope LM, Graciani A, Luque M, de la Cruz-Troca JJ, Garcia-Robles R, Tamargo J, Rey-Calero J. Hypertens magnitude and management in the elderly population of Spain. J Hypertens. 2002;20:2157-2164.
8. Lozano JV, Redon J, Cea-Calvo L, Fernandez-Perez C, Navarro J, Bonet A, Gonzalez-Esteban J; Investigadores del Estudio ERIC-HTA 2003. [Evaluation of first stroke risk in Spanish hypertensives attending Primary Care. The ERIC-HTA study]. Med Clin (Barc) 2005;125:247-251.
9. Coca A, Redon J, Cea-Calvo L, Lozano JV, Navarro J, Fernandez-Perez C, Gonzalez-Esteban J. Estimated risk of a first stroke and conditioning factors in Spanish hypertensive population. The RIMHA study. Blood Press. 2006;15:237-244.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr , Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA. 2003;289:2560-2572.
11. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
12. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-147.
13. Topouchian J, Orobinskaya L, El Assaad M, Asmar R. Validation of the OMRON M6 (HEM -7001-E) blood pressure measuring device according to the International Protocol of the European Society of Hypertension. Available at: http://www.ajmedical.se/OmronM6_Validering.pdf. Accessed on July 19, 2006.
14. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation. 1987;75:565-572.
15. Sokolow M, Lyon T. Ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161-186.
16. D'Agostino R, Wolf PA, Belanger A, Kannel W. Stroke risk profile: adjustment for antihipertensive medication. The Framinghan Study. Stroke. 1994;25:40-43.
17. Instituto Nacional de Estadística. Cifras de Población. Available at: http://www.ine.es/inebase/cgi/um?M=%2Ft20%2Fe260&O= inebase&N=&L=. Accessed on: July 1, 2006.
18. Instituto de Demografía (1994), Proyección de la población española. Madrid, Instituto de Demografía/C.S.I.C. Avaialble at: http://www.ced.uab.es/publicacions/PapersPDF/Text174.pdf. Accessed on: July 19, 2006.
19. Ministerio de Sanidad. http://www.msc.es/estadEstudios/estadisticas/home. htm. Accessed on: July 19, 2006.
20. Mancia G, Ambrosioni E, Rosei EA, Leonetti G, Trimarco B, Volpe M Blood pressure control and risk for stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens. 2005;23:1575-1581.
21. Roux O, Chapellier M, Czernichow S, Nisse-Durgeat S, Safar ME, Blacher J. Determinants of hypertension control in a large French population of treated hypertensive subjects. Blood Press. 2006;15:6-13.
22. Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, Carmona J. Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens. 2005;23:1661-1666.
23. Steckelings UM, Stoppelhaar M, Sharma AM, Wittchen HU, Krause P, Kupper B, Kirch W, Pittrow D, Ritz E, Goke B, Lehnert H, Tschope D, Hofler M, Pfister H, Unger T; HYDRA Study Group. HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients. Blood Press. 2004;13:80-88.
24. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens. 2006;24:1187-1192.
25. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood Pressure, Stroke, and Coronary Heart Disease, Part 1: prolonged differences in blood pressure. Prospective observational studies corrected for the regression dilution bias. Lancet. 1990;355:765-774.
26. Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res. 2005;28:385-407.
27. Staessen JA, Wang JG, Thijs L, Fagard R. Overview of the outcome trials in older patients with isolated systolic hypertension. J Hum Hypertens. 1999;13:859-863.
28. Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, Ambrosio G. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation. 2001;104:2039-2044.
29. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N-9N.
30. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J. 1990;120:672-676.
31. Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, Heiss G. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care. 1999;22:1077-1083.
32. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlof B; LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292:2343-2349.
33. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL; American Heart Association; American Stroke Association Stroke Council. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006;113:873-923.
34. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA. 2003;290:1049-1056.